Piper Jaffray Remains Sidelined as Cost Cuts Drive ITT Educational Services' (ESI) EPS Beat

Go back to Piper Jaffray Remains Sidelined as Cost Cuts Drive ITT Educational Services' (ESI) EPS Beat

After-Hours Stock Movers 03/14: (CPXX) (SZYM) (ESI) Higher; (IMMU) (MNKD) (NVIV) Lower (more...)

March 14, 2016 6:09 PM EDT

Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) 373% HIGHER; announced positive results from the Phase 3 trial of VYXEOS (cytarabine: daunorubicin) Liposome for Injection (also known as CPX-351) in patients with high-risk (secondary) acute myeloid leukemia (AML) compared to the standard of care regimen of cytarabine and daunorubicin known as 7+3. The trial met its primary endpoint demonstrating a statistically significant improvement in overall survival.

Solazyme, Inc. (Nasdaq: SZYM) 29.5% HIGHER; has signed a definitive multi-year global supply agreement with Unilever.... More

ITT Educational Services (ESI) Posts Q4 EPS of $0.44; Will Restate Certain Financials

March 14, 2016 4:44 PM EDT

ITT Educational Services (NYSE: ESI) reported Q4 EPS of $0.44, $0.26 better than the analyst estimate of $0.18. Revenue for the quarter came in at $202.4 million versus the consensus estimate of $203.3 million.

Based on various assumptions, including the historical and projected performance and collection of the student loans held by the PEAKS Trust and the CUSO, the company reported that its current estimate of the payments it may have to make under the PEAKS guarantee and the CUSO risk sharing agreement (the "CUSO RSA"), in the aggregate, are approximately:

$27.7 million in 2016;
$13.1 million in 2017;
$13.4 million... More